Literature DB >> 3122787

Clinical manifestations of acute infection with human immunodeficiency virus in a cohort of gay men.

R Fox1, L J Eldred, E J Fuchs, R A Kaslow, B R Visscher, M Ho, J P Phair, B F Polk.   

Abstract

During a prospective study of the natural history of human immunodeficiency virus (HIV) infection in a cohort of gay/bisexual men, information on self-reported symptoms lasting for 3 or more days during the previous 6 months was collected without knowledge of the subject's HIV serological status. Twenty-two people were retrospectively found to have seroconverted to HIV during the interval. Each seroconverter was matched to two seronegative and two seropositive controls. Matched case-control analyses using the seronegative controls determined that the following symptoms lasting for 3 or more days were associated with new HIV infection: fever greater than 37.7 degrees C, swollen lymph nodes, night sweats and headaches. Matched case-control analyses using the seropositive controls determined that the following symptoms lasting for 3 or more days were associated with new HIV infection: fatigue, fever greater than 37.7 degrees C, swollen lymph nodes, night sweats and headaches. It was notable that the majority of seroconversions were not associated with any symptoms lasting for 3 or more days. Due to their non-specificity, symptoms associated with seroconversion are not likely to have a high positive predictive value. In high risk populations, however, appearance of these symptoms may facilitate identification of early infection that may be important for studies of natural history or for optimal timing for initiating antiviral therapy.

Entities:  

Mesh:

Year:  1987        PMID: 3122787

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV.

Authors:  R N Lucille Sanzero Eller
Journal:  Ann Behav Med       Date:  1995-12

Review 2.  Human immunodeficiency virus and hepatitis--implications for operating room personnel.

Authors:  S Colbert; G J Sheehan
Journal:  Ir J Med Sci       Date:  1995-01       Impact factor: 1.568

3.  Acute Retroviral Syndrome Is Associated With High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.

Authors:  Trevor A Crowell; Donn J Colby; Suteeraporn Pinyakorn; James L K Fletcher; Eugène Kroon; Alexandra Schuetz; Shelly J Krebs; Bonnie M Slike; Louise Leyre; Nicolas Chomont; Linda L Jagodzinski; Irini Sereti; Netanya S Utay; Robin Dewar; Rungsun Rerknimitr; Nitiya Chomchey; Rapee Trichavaroj; Victor G Valcour; Serena Spudich; Nelson L Michael; Merlin L Robb; Nittaya Phanuphak; Jintanat Ananworanich
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

Review 4.  Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.

Authors:  Michael Maes; Frank N M Twisk
Journal:  BMC Med       Date:  2010-06-15       Impact factor: 8.775

Review 5.  Neurologic presentations of AIDS.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah Commins; Andrew Levine
Journal:  Neurol Clin       Date:  2010-02       Impact factor: 3.806

6.  Clinical manifestations and the natural history of HIV infection in adults.

Authors:  P Piot; R Colebunders
Journal:  West J Med       Date:  1987-12

7.  Influenza-like syndrome in homosexual men: a prospective diagnostic study.

Authors:  F de Wolf; J M Lange; M Bakker; S Tjong-A-Hung; C Hooykaas; R Coutinho; J van der Noordaa; J Goudsmit
Journal:  J R Coll Gen Pract       Date:  1988-10

8.  A novel Acute Retroviral Syndrome Severity Score predicts the key surrogate markers for HIV-1 disease progression.

Authors:  Dominique L Braun; Roger Kouyos; Corinna Oberle; Christina Grube; Beda Joos; Jacques Fellay; Paul J McLaren; Herbert Kuster; Huldrych F Günthard
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.